CEMEX SAB-SPONS ADR PART CER (CX) Stock Fundamental Analysis
NYSE:CX - US1512908898 - ADR
8.93 USD
-0.04 (-0.45%)
8.95 USD
+0.02 (+0.22%)
Overall CX gets a fundamental rating of 3 out of 10. We evaluated CX against 13 industry peers in the Construction Materials industry. There are concerns on the financial health of CX while its profitability can be described as average. CX has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
CX had positive earnings in the past year.
In the past year CX had a positive cash flow from operations.
CX had positive earnings in 4 of the past 5 years.
In the past 5 years CX always reported a positive cash flow from operatings.
1.2 Ratios
CX has a Return On Assets of 5.23%. This is in the lower half of the industry: CX underperforms 69.23% of its industry peers.
CX has a Return On Equity of 11.27%. This is in the lower half of the industry: CX underperforms 69.23% of its industry peers.
CX has a worse Return On Invested Capital (5.19%) than 84.62% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CX is below the industry average of 10.36%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.23% | ||
| ROE | 11.27% | ||
| ROIC | 5.19% |
ROA(3y)2.44%
ROA(5y)0.96%
ROE(3y)5.81%
ROE(5y)1.39%
ROIC(3y)6.81%
ROIC(5y)6.3%
1.3 Margins
The Profit Margin of CX (9.61%) is worse than 61.54% of its industry peers.
CX's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 9.30%, CX is doing worse than 76.92% of the companies in the same industry.
CX's Operating Margin has improved in the last couple of years.
CX has a Gross Margin of 32.53%. This is in the better half of the industry: CX outperforms 76.92% of its industry peers.
CX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.3% | ||
| PM (TTM) | 9.61% | ||
| GM | 32.53% |
OM growth 3Y-1.91%
OM growth 5Y2.21%
PM growth 3Y3.44%
PM growth 5Y39.71%
GM growth 3Y1.36%
GM growth 5Y0.48%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CX is destroying value.
Compared to 1 year ago, CX has an improved debt to assets ratio.
2.2 Solvency
CX has an Altman-Z score of 1.48. This is a bad value and indicates that CX is not financially healthy and even has some risk of bankruptcy.
CX has a worse Altman-Z score (1.48) than 69.23% of its industry peers.
CX has a debt to FCF ratio of 63.21. This is a negative value and a sign of low solvency as CX would need 63.21 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 63.21, CX is doing worse than 61.54% of the companies in the same industry.
A Debt/Equity ratio of 0.45 indicates that CX is not too dependend on debt financing.
The Debt to Equity ratio of CX (0.45) is better than 69.23% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.45 | ||
| Debt/FCF | 63.21 | ||
| Altman-Z | 1.48 |
ROIC/WACC0.37
WACC13.9%
2.3 Liquidity
A Current Ratio of 0.86 indicates that CX may have some problems paying its short term obligations.
CX's Current ratio of 0.86 is on the low side compared to the rest of the industry. CX is outperformed by 84.62% of its industry peers.
A Quick Ratio of 0.61 indicates that CX may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.61, CX is doing worse than 76.92% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.86 | ||
| Quick Ratio | 0.61 |
3. Growth
3.1 Past
The earnings per share for CX have decreased strongly by -81.56% in the last year.
Measured over the past years, CX shows a very strong growth in Earnings Per Share. The EPS has been growing by 76.58% on average per year.
Looking at the last year, CX shows a very negative growth in Revenue. The Revenue has decreased by -25.98% in the last year.
CX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.29% yearly.
EPS 1Y (TTM)-81.56%
EPS 3Y-35.5%
EPS 5Y76.58%
EPS Q2Q%0%
Revenue 1Y (TTM)-25.98%
Revenue growth 3Y4.05%
Revenue growth 5Y4.29%
Sales Q2Q%-8.2%
3.2 Future
Based on estimates for the next years, CX will show a very negative growth in Earnings Per Share. The EPS will decrease by -18.89% on average per year.
CX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.14% yearly.
EPS Next Y-57.31%
EPS Next 2Y-36.73%
EPS Next 3Y-18.89%
EPS Next 5YN/A
Revenue Next Year-4.11%
Revenue Next 2Y-0.34%
Revenue Next 3Y1.96%
Revenue Next 5Y4.14%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 9.02 indicates a reasonable valuation of CX.
Based on the Price/Earnings ratio, CX is valued cheaper than 100.00% of the companies in the same industry.
CX is valuated cheaply when we compare the Price/Earnings ratio to 27.14, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 3.85, the valuation of CX can be described as very cheap.
Based on the Price/Forward Earnings ratio, CX is valued cheaper than 100.00% of the companies in the same industry.
CX is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.80, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.02 | ||
| Fwd PE | 3.85 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CX indicates a rather cheap valuation: CX is cheaper than 100.00% of the companies listed in the same industry.
CX's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 118.32 | ||
| EV/EBITDA | 6.73 |
4.3 Compensation for Growth
A cheap valuation may be justified as CX's earnings are expected to decrease with -18.89% in the coming years.
PEG (NY)N/A
PEG (5Y)0.12
EPS Next 2Y-36.73%
EPS Next 3Y-18.89%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 28.45%, CX is a good candidate for dividend investing.
CX's Dividend Yield is rather good when compared to the industry average which is at 4.31. CX pays more dividend than 100.00% of the companies in the same industry.
CX's Dividend Yield is rather good when compared to the S&P500 average which is at 2.34.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 28.45% |
5.2 History
CX has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
8.08% of the earnings are spent on dividend by CX. This is a low number and sustainable payout ratio.
DP8.08%
EPS Next 2Y-36.73%
EPS Next 3Y-18.89%
8.93
-0.04 (-0.45%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)
Earnings (Next)
Inst Owners18.83%
Inst Owner Change3.59%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap12.96B
Analysts81.33
Price Target8.82 (-1.23%)
Short Float %2.02%
Short Ratio2.37
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 28.45% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP8.08%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-27.18%
Min EPS beat(2)-51.46%
Max EPS beat(2)-2.91%
EPS beat(4)0
Avg EPS beat(4)-44.5%
Min EPS beat(4)-88.35%
Max EPS beat(4)-2.91%
EPS beat(8)1
Avg EPS beat(8)139.52%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.97%
Min Revenue beat(2)-6.15%
Max Revenue beat(2)-1.8%
Revenue beat(4)0
Avg Revenue beat(4)-5.28%
Min Revenue beat(4)-8.32%
Max Revenue beat(4)-1.8%
Revenue beat(8)0
Avg Revenue beat(8)-4.42%
Revenue beat(12)1
Avg Revenue beat(12)-3.81%
Revenue beat(16)2
Avg Revenue beat(16)1.5%
PT rev (1m)17.27%
PT rev (3m)37.39%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)19.99%
EPS NY rev (3m)19.99%
Revenue NQ rev (1m)0.09%
Revenue NQ rev (3m)4.09%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)0.07%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.02 | ||
| Fwd PE | 3.85 | ||
| P/S | 0.83 | ||
| P/FCF | 118.32 | ||
| P/OCF | 8.04 | ||
| P/B | 0.97 | ||
| P/tB | 3.41 | ||
| EV/EBITDA | 6.73 |
EPS(TTM)0.99
EY11.09%
EPS(NY)2.32
Fwd EY25.95%
FCF(TTM)0.08
FCFY0.85%
OCF(TTM)1.11
OCFY12.44%
SpS10.8
BVpS9.21
TBVpS2.62
PEG (NY)N/A
PEG (5Y)0.12
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.23% | ||
| ROE | 11.27% | ||
| ROCE | 6.57% | ||
| ROIC | 5.19% | ||
| ROICexc | 5.54% | ||
| ROICexgc | 10.25% | ||
| OM | 9.3% | ||
| PM (TTM) | 9.61% | ||
| GM | 32.53% | ||
| FCFM | 0.7% |
ROA(3y)2.44%
ROA(5y)0.96%
ROE(3y)5.81%
ROE(5y)1.39%
ROIC(3y)6.81%
ROIC(5y)6.3%
ROICexc(3y)7.18%
ROICexc(5y)6.61%
ROICexgc(3y)13.44%
ROICexgc(5y)12.5%
ROCE(3y)8.62%
ROCE(5y)7.97%
ROICexcg growth 3Y3.59%
ROICexcg growth 5Y8.98%
ROICexc growth 3Y3.55%
ROICexc growth 5Y10.09%
OM growth 3Y-1.91%
OM growth 5Y2.21%
PM growth 3Y3.44%
PM growth 5Y39.71%
GM growth 3Y1.36%
GM growth 5Y0.48%
F-Score5
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.45 | ||
| Debt/FCF | 63.21 | ||
| Debt/EBITDA | 2.21 | ||
| Cap/Depr | 119.14% | ||
| Cap/Sales | 9.58% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 59.27% | ||
| Profit Quality | 7.27% | ||
| Current Ratio | 0.86 | ||
| Quick Ratio | 0.61 | ||
| Altman-Z | 1.48 |
F-Score5
WACC13.9%
ROIC/WACC0.37
Cap/Depr(3y)98.23%
Cap/Depr(5y)87.02%
Cap/Sales(3y)7.21%
Cap/Sales(5y)6.61%
Profit Quality(3y)217.11%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-81.56%
EPS 3Y-35.5%
EPS 5Y76.58%
EPS Q2Q%0%
EPS Next Y-57.31%
EPS Next 2Y-36.73%
EPS Next 3Y-18.89%
EPS Next 5YN/A
Revenue 1Y (TTM)-25.98%
Revenue growth 3Y4.05%
Revenue growth 5Y4.29%
Sales Q2Q%-8.2%
Revenue Next Year-4.11%
Revenue Next 2Y-0.34%
Revenue Next 3Y1.96%
Revenue Next 5Y4.14%
EBIT growth 1Y-35.45%
EBIT growth 3Y2.07%
EBIT growth 5Y6.6%
EBIT Next Year58.46%
EBIT Next 3Y19.8%
EBIT Next 5YN/A
FCF growth 1Y-85.91%
FCF growth 3Y-11.58%
FCF growth 5Y-3.16%
OCF growth 1Y-23.12%
OCF growth 3Y0.91%
OCF growth 5Y6.96%